KTM
AMGN icon

Keeler Thomas Management’s Amgen AMGN Stock Holding History

Keeler Thomas Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-3,707
Closed -$896K – 63
2023
Q1 		$896K Sell
3,707
-14,331
-79% -$3.52M 0.42% 51
2022
Q4 		$4.74M Sell
18,038
-108
-0.6% -$29K 2.39% 12
2022
Q3 		$4.09M Buy
18,146
+4,008
+28% +$972K 2.08% 18
2022
Q2 		$3.44M Buy
14,138
+231
+2% +$56.6K 1.7% 20
2022
Q1 		$3.36M Sell
13,907
-142
-1% -$32.6K 1.61% 22
2021
Q4 		$3.16M Sell
14,049
-474
-3% -$100K 1.37% 30
2021
Q3 		$3.1M Buy
14,523
+1,164
+9% +$268K 1.47% 31
2021
Q2 		$3.26M Buy
13,359
+214
+2% +$52.6K 1.59% 32
2021
Q1 		$3.27M Buy
13,145
+1,876
+17% +$448K 1.72% 31
2020
Q4 		$2.62M Buy
11,269
+4,156
+58% +$958K 1.47% 28
2020
Q3 		$1.81M Buy
+7,113
New +$1.76M 1.14% 33
2018
Q1 		– Sell
-189
Closed -$32K – 57
2017
Q4 		$32K Buy
+189
New +$33.4K 0.03% 108

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Keeler Thomas Management's AMGN Position: Q2 2023 in Review

Keeler Thomas Management sold out of Amgen (AMGN) in Q2 2023, closing a stake of 3,707 shares — an estimated $896K sold.

Keeler Thomas Management first reported a position in AMGN in Q4 2017 and held it in 12 quarters. The position peaked at $4.74M in Q4 2022. 2,390 funds tracked by Wall St. Rank hold AMGN as of Q2 2023.

  • Keeler Thomas Management reported no remaining Amgen position as of Q2 2023 after selling out during the quarter.
  • Keeler Thomas Management sold 3,707 Amgen shares in Q2 2023, an estimated $896K.
  • Keeler Thomas Management first reported a position in Amgen in Q4 2017 and held it in 12 quarters.
  • Keeler Thomas Management's Amgen position peaked at $4.74M in Q4 2022.
  • 2,390 funds tracked by Wall St. Rank held Amgen as of Q2 2023.

Based on Keeler Thomas Management's 13F filing for Q2 2023, filed 21 Jul 2023.